Treatment of Resistant Periungual Warts
For resistant periungual warts, intralesional bleomycin (0.1-1 mg/mL) is the most effective treatment, with cure rates exceeding 85-96% and minimal risk of permanent nail damage when properly administered.
Primary Recommendation: Intralesional Bleomycin
The British Association of Dermatologists guidelines 1 give bleomycin a Strength B recommendation for hand warts, specifically noting a 0.1-1 mg/mL solution injected or pricked into the wart after local anesthesia, requiring one to three treatments. This is the highest-level recommendation specifically addressing resistant periungual warts.
Why Bleomycin is Superior for Periungual Warts
Multiple high-quality studies demonstrate bleomycin's exceptional efficacy in this challenging location:
- Diluted bleomycin (0.1 U/mL) achieved 86.6% complete clearance with just one injection in a prospective study, with only 2 recurrences at 6-month follow-up 2
- Standard concentration (1 mg/mL) showed 96.47% cure rate in palmoplantar and periungual warts 3
- Even in immunocompromised patients, complete clearance was achieved with diluted bleomycin 4
- A 2012 review concluded that "intralesional bleomycin appears to be the most effective treatment for periungual warts" 5
Administration Technique
Use the translesional multipuncture technique rather than direct injection:
- Dilute to 0.1-0.5 U/mL for periungual location (lower concentration reduces pain and nail damage risk)
- Apply local anesthesia first
- Multiple punctures through the wart deliver medication while minimizing pressure-related pain
- Repeat every 2-4 weeks if needed (most clear with 1-2 treatments)
- Expect hemorrhagic eschar formation that heals in 8-12 weeks 3
Expected Side Effects
- Moderate localized pain for 2-3 days (60% of patients) 2
- Temporary mild hyperpigmentation (rare, resolves in 1 month)
- No permanent nail matrix damage when properly dosed
Alternative Options When Bleomycin is Unavailable
If bleomycin cannot be obtained or is contraindicated:
Second-Line: Contact Immunotherapy
DPC or SADBE (Strength C recommendation 1) applied from twice weekly to every 3 weeks for 3-6 months. Requires initial sensitization but avoids destructive techniques near the nail matrix.
Third-Line: Local Hyperthermia
Heat wart to 44°C for 30 minutes on three to five consecutive days 1. Two 2022 case reports showed complete clearance of stubborn periungual warts with this method 6. This is particularly attractive because it's:
- Non-invasive
- No risk of nail damage
- Can be done at home after initial instruction
- Inexpensive
Fourth-Line: Pulsed-Dye Laser
7-10 J/cm² for 2-4 treatments after paring (Strength C recommendation 1). More expensive but avoids injection pain.
Critical Pitfalls to Avoid
- Avoid aggressive cryotherapy near the nail matrix - high risk of permanent nail dystrophy and poor efficacy in this location
- Don't use full-strength bleomycin (1 mg/mL) initially for periungual warts - start with 0.1-0.5 U/mL to minimize pain and complications
- Avoid surgical excision/curettage for periungual warts unless absolutely necessary - high recurrence rates and permanent nail damage risk
- Don't give up after 3 months - periungual warts may require 3-6 months of treatment even with effective modalities
Treatment Algorithm
- First attempt: Intralesional bleomycin 0.1-0.5 U/mL via multipuncture technique, repeat at 2-4 weeks if needed
- If bleomycin unavailable: Local hyperthermia (44°C × 30 min × 3-5 consecutive days) OR contact immunotherapy
- If still resistant after 2-3 bleomycin treatments: Consider pulsed-dye laser or combination with topical 5-fluorouracil under occlusion
- For immunocompromised patients: Still use bleomycin as first-line (proven effective even in this population 4)
The key advantage of bleomycin is that it works quickly (often 1-2 treatments vs. months of other therapies), has minimal long-term complications when properly administered, and specifically addresses the challenge of poor drug penetration in the periungual location 5.